Cargando…

PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.

Detalles Bibliográficos
Autores principales: Monard, Amaury, Heubel-Moenen, Fs.C.J.I., Castoldi, Elisabetta, De Simone, Ilaria, van der Meijden, P.E.J., Wichapong, Kanin, van Doorn, W.P.T.M., Spada, Stefano, Hellenbrand, D.L.S., Stork, A.D.M., Cate, Hugo Ten, Beckers, E.A.M., Henskens, Y.M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429631/
http://dx.doi.org/10.1097/01.HS9.0000977252.70104.05
_version_ 1785090763195940864
author Monard, Amaury
Heubel-Moenen, Fs.C.J.I.
Castoldi, Elisabetta
De Simone, Ilaria
van der Meijden, P.E.J.
Wichapong, Kanin
van Doorn, W.P.T.M.
Spada, Stefano
Hellenbrand, D.L.S.
Stork, A.D.M.
Cate, Hugo Ten
Beckers, E.A.M.
Henskens, Y.M.C.
author_facet Monard, Amaury
Heubel-Moenen, Fs.C.J.I.
Castoldi, Elisabetta
De Simone, Ilaria
van der Meijden, P.E.J.
Wichapong, Kanin
van Doorn, W.P.T.M.
Spada, Stefano
Hellenbrand, D.L.S.
Stork, A.D.M.
Cate, Hugo Ten
Beckers, E.A.M.
Henskens, Y.M.C.
author_sort Monard, Amaury
collection PubMed
description
format Online
Article
Text
id pubmed-10429631
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104296312023-08-17 PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION. Monard, Amaury Heubel-Moenen, Fs.C.J.I. Castoldi, Elisabetta De Simone, Ilaria van der Meijden, P.E.J. Wichapong, Kanin van Doorn, W.P.T.M. Spada, Stefano Hellenbrand, D.L.S. Stork, A.D.M. Cate, Hugo Ten Beckers, E.A.M. Henskens, Y.M.C. Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429631/ http://dx.doi.org/10.1097/01.HS9.0000977252.70104.05 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Monard, Amaury
Heubel-Moenen, Fs.C.J.I.
Castoldi, Elisabetta
De Simone, Ilaria
van der Meijden, P.E.J.
Wichapong, Kanin
van Doorn, W.P.T.M.
Spada, Stefano
Hellenbrand, D.L.S.
Stork, A.D.M.
Cate, Hugo Ten
Beckers, E.A.M.
Henskens, Y.M.C.
PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
title PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
title_full PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
title_fullStr PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
title_full_unstemmed PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
title_short PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
title_sort pb2642: evaluation of innovative laboratory tests to predict a thrombotic phenotype in a family with dysfibrinogenemia and a novel fgg mutation.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429631/
http://dx.doi.org/10.1097/01.HS9.0000977252.70104.05
work_keys_str_mv AT monardamaury pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT heubelmoenenfscji pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT castoldielisabetta pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT desimoneilaria pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT vandermeijdenpej pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT wichapongkanin pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT vandoornwptm pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT spadastefano pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT hellenbranddls pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT storkadm pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT catehugoten pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT beckerseam pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation
AT henskensymc pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation